[Treatment of advanced hormone-sensitive prostate cancer using degarelix] [0.03%]
[使用degarelix治疗晚期激素敏感性前列腺癌]
Nikolaos Pyrgidis,Georgios Hatzichristodoulou,Ioannis Sokolakis
Nikolaos Pyrgidis
[Stockholm3 (STHLM3) MRI-on the pathway toward multimodal diagnostic approach for prostate cancer?] [0.03%]
Stockholm3(STHLM3)MRI-迈向前列腺癌多模式诊断方法的路径?
Jan Lukas Hohenhorst,Fabian Falkenbach,Lars Budäus
Jan Lukas Hohenhorst